Clinical Trial: FDA Approved Medication to Reduce Binge Eating and/or Purging

Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Interventional

---

Official Title: Qsymia (Phentermine-topiramate) to Reduce Binge Eating/Purging in Patients With Bulimia Nervosa and Binge Eating

Brief Summary: This study will demonstrate the efficacy of Qsymia versus placebo in treating bulimia nervosa and binge eating disorder.